Identifying Clinical Predictors of Proliferative Sickle Cell Retinopathy

References

• Menaa F, Khan BA, Uzair B, Menaa A. Sickle cell retinopathy: improving care with a multidisciplinary approach. J Multidiscip Healthc. 2017; 10:335–346. doi: 10.2147/JMDH.S90630.
   PubMed Web of Science ®Google Scholar
• Pinto VM, Balocco M, Quintino S, Forni GL. Sickle cell disease: a review for the internist. Intern Emerg Med. 2019; 14(7):1051–1064. doi: 10.1007/s11739-019-02160-x.
   PubMed Web of Science ®Google Scholar
• Abdalla Elsayed MEA, Mura M, Al Dhibi H, Schellini S, Malik R, Kozak I, Schatz P. Sickle cell retinopathy. A focused review. Graefes Arch Clin Exp Ophthalmol. 2019; 257(7):1353–1364. doi: 10.1007/s00417-019-04294-2.
   PubMed Web of Science ®Google Scholar
• Goldberg MF. Classification and pathogenesis of proliferative sickle retinopathy. Am J Ophthalmol. 1971; 71(3):649–665. doi: 10.1016/0002-9394(71)90429-6.
   PubMed Web of Science ®Google Scholar
• Elagouz M, Jyothi S, Gupta B, Sivaprasad S. Sickle cell disease and the eye: old and new concepts. Surv Ophthalmol. 2010; 55(4):359–377. doi: 10.1016/j.survophthal.2009.11.004.
   PubMed Web of Science ®Google Scholar
• Galinos SO, Asdourian GK, Woolf MB, Stevens T, Lee C, Goldberg M, Chow JC, Busse BJ. Spontaneous remodeling of the peripheral retinal vasculature in sickling disorders. Am J Ophthalmol. 1975; 79(5):853–870. doi: 10.1016/0002-9394(75)90747-3.
   PubMed Web of Science ®Google Scholar
• Mokrane A, Gazeau G, Lévy V, Fajnkuchen F, Giocanti-Aurégan A. Analysis of the foveal microvasculature in sickle cell disease using swept-source optical coherence tomography angiography. Sci Rep. 2020; 10(1):11795. doi: 10.1038/s41598-020-68625-8.
   PubMedGoogle Scholar
• El-Ghamrawy MK, El Behairy HF, El Menshawy A, Awad S, Ismail A, Gabal M. Ocular manifestations in Egyptian children and young adults with sickle cell disease. Indian J Hematol Blood Transfus. 2014; 30(4):275–280. doi: 10.1007/s12288-014-0333-0.
   PubMed Web of Science ®Google Scholar
• Leveziel N, Bastuji-Garin S, Lalloum F, Querques G, Benlian P, Binaghi M, Coscas G, Soubrane G, Bachir D, Galactéros F, et al. Clinical and laboratory factors associated with the severity of proliferative sickle cell retinopathy in patients with sickle cell hemoglobin C (SC) and homozygous sickle cell (SS) disease. Medicine. 2011; 90(6):372–378. doi: 10.1097/MD.0b013e3182364cba.
   PubMed Web of Science ®Google Scholar
• Dembélé AK, Toure BA, Sarro YS, Guindo A, Fané B, Offredo L, Kené S, Conaré I, Tessougué O, Traoré Y, et al. Prevalence and risk factors for sickle retinopathy in a sub-Saharan comprehensive Sickle Cell Center. Rev Med Interne. 2017; 38(9):572–577.
   PubMed Web of Science ®Google Scholar
• Downes SM, Hambleton IR, Chuang EL, Lois N, Serjeant G, Bird A. Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study. Ophthalmology. 2005; 112(11):1869–1875. doi: 10.1016/j.ophtha.2005.05.026.
   PubMed Web of Science ®Google Scholar
• Leveziel N, Lalloum F, Bastuji-Garin S, Binaghi M, Bachir D, Galacteros F, Souied E. Sickle-cell retinopathy: retrospective study of 730 patients followed in a referral center. J Fr Ophtalmol. 2012; 35(5):343–347. doi: 10.1016/j.jfo.2011.10.007.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Wei X, Goud A, Vupparaboina K, Jana S, Chhablani J. Influence of scanning area on choroidal vascularity index measurement using optical coherence tomography. Acta Ophthalmol. 2017; 95(8):e770–5–e775. doi: 10.1111/aos.13442.
   Web of Science ®Google Scholar
• Zudaire E, Gambardella L, Kurcz C, Vermeren S. A computational tool for quantitative analysis of vascular networks. PLoS One. 2011; 6(11):e27385. doi: 10.1371/journal.pone.0027385.
   PubMed Web of Science ®Google Scholar
• Scott AW. Ophthalmic manifestations of sickle cell disease. South Med J. 2016; 109(9):542–548. doi: 10.14423/SMJ.0000000000000525.
   PubMed Web of Science ®Google Scholar
• Colella MP, de Paula EV, Machado-Neto JA, Conran N, Annichino-Bizzacchi J, Costa F, Olalla Saad S, Traina F. Elevated hypercoagulability markers in hemoglobin SC disease. Haematologica. 2015; 100(4):466–471. doi: 10.3324/haematol.2014.114587.
   PubMed Web of Science ®Google Scholar
• Lemaire C, Lamarre Y, Lemonne N, Waltz X, Chahed S, Cabot F, Botez I, Tressieres B, Lalanne-Mistrih M, Etienne-Julan M, et al. Sereve proliferative retinopathy is associated with blood hyperviscosity in sickle cell hemoglobin-C disease but not in sickle cell anemia. Clin Hemorheol Microcirc. 2013; 55(2):205–212. doi: 10.3233/CH-2012-1622.
   PubMed Web of Science ®Google Scholar
• Duan XJ, Lanzkron S, Linz MO, Ewing C, Wang J, Scott A. Clinical and ophthalmic factors associated with the severity of sickle cell retinopathy. Am J Ophthalmol. 2019;197:105–113. doi: 10.1016/j.ajo.2018.09.025.
   PubMed Web of Science ®Google Scholar
• Fox PD, Dunn DT, Morris JS, Serjeant GR. Risk factors for proliferative sickle retinopathy. Br J Ophthalmol. 1990; 74(3):172–176. doi: 10.1136/bjo.74.3.172.
   PubMed Web of Science ®Google Scholar
• Estepp JH, Smeltzer MP, Wang WC, Hoehn M, Hankins J, Aygun B. Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children. Br J Haematol. 2013; 161(3):402–405. doi: 10.1111/bjh.12238.
   PubMed Web of Science ®Google Scholar
• Stojanovic K, Lionnet F. Lactate dehydrogenase in sickle cell disease. Clin Chim Acta. 2016; 458:99–102. doi: 10.1016/j.cca.2016.04.035.
   PubMed Web of Science ®Google Scholar
• Nawaiseh M, Roto A, Nawaiseh Y, Salameh M, Haddadin R, Mango L, Nawaiseh H, Alsaraireh D, Nawaiseh Q, AlRyalat S, et al. Risk factors associated with sickle cell retinopathy: findings from the cooperative study of sickle cell disease. Int J Retina Vitreous. 2022; 8(1):68.
   PubMedGoogle Scholar
• Lynch G, Scott AW, Linz MO, Han I, Romo J, Linderman R, Carroll J, Rosen R, Chui TY. Foveal avascular zone morphology and parafoveal capillary perfusion in sickle cell retinopathy. Br J Ophthalmol. 2020; 104(4):473–479. doi: 10.1136/bjophthalmol-2019-314567.
   PubMed Web of Science ®Google Scholar
• Fares S, Hajjar S, Romana M, Connes P, Acomat M, Zorobabel C, Zuber K, Boulanger-Scemama E, Etienne-Julan M, David T, et al. Sickle cell maculopathy: microstructural analysis using OCTA and identification of genetic, systemic, and biological risk factors. Am J Ophthalmol. 2021; 224:7–17. doi: 10.1016/j.ajo.2020.11.019.
   PubMed Web of Science ®Google Scholar
• Alam M, Thapa D, Lim JI, Cao D, Yao X. Quantitative characteristics of sickle cell retinopathy in optical coherence tomography angiography. Biomed Opt Express. 2017; 8(3):1741–1753. doi: 10.1364/BOE.8.001741.
   PubMed Web of Science ®Google Scholar
• Mathew R, Bafiq R, Ramu J, Pearce E, Richardson M, Drasar E, Thein S, Sivaprasad S. Spectral domain optical coherence tomography in patients with sickle cell disease. Br J Ophthalmol. 2015; 99(7):967–972. doi: 10.1136/bjophthalmol-2014-305532.
   PubMed Web of Science ®Google Scholar
• Hoang QV, Chau FY, Shahidi M, Lim JI. Central macular splaying and outer retinal thinning in asymptomatic sickle cell patients by spectral domain optical coherence tomography. Am J Ophthalmol. 2011; 151(6):990–994.e1. doi: 10.1016/j.ajo.2010.12.010.
   PubMed Web of Science ®Google Scholar
• Chow CC, Genead MA, Anastasakis A, Chau F, Fishman G, Lim J. Structural and functional correlation in sickle cell retinopathy using spectral-domain optical coherence tomography and scanning laser ophthalmoscope microperimetry. Am J Ophthalmol. 2011; 152(4):704–711.e2. doi: 10.1016/j.ajo.2011.03.035.
   PubMed Web of Science ®Google Scholar
• Minvielle W, Caillaux V, Cohen SY, Chasset F, Zambrowski O, Miere A, Souied E. Macular microangiopathy in sickle cell disease using optical coherence tomography angiography. Am J Ophthalmol. 2016; 164:137–144.e1. doi: 10.1016/j.ajo.2015.12.023.
   PubMed Web of Science ®Google Scholar
• Roemer S, Bergin C, Kaeser PF, Ambresin A. Assessment of macular vasculature of children with sickle cell disease compared to that of healthy controls using optical coherence tomography angiography. Retina. 2019;39(12):2384–2391. doi: 10.1097/IAE.0000000000002321.
   PubMed Web of Science ®Google Scholar
• Sanders RJ, Brown GC, Rosenstein RB, Magargal L. Foveal avascular zone diameter and sickle cell disease. Arch Ophthalmol. 1991; 109(6):812–815. doi: 10.1001/archopht.1991.01080060076029.
   PubMedGoogle Scholar